Algernon Pharmaceuticals (Algernon Pharmaceuticals) PB Ratio : 1.95 (As of Apr. 26, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Algernon Pharmaceuticals PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-26), Algernon Pharmaceuticals's share price is $0.091435. Algernon Pharmaceuticals's Book Value per Share for the quarter that ended in Nov. 2023 was $0.05. Hence, Algernon Pharmaceuticals's PB Ratio of today is 1.95.

The historical rank and industry rank for Algernon Pharmaceuticals's PB Ratio or its related term are showing as below:

AGNPF' s PB Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 18.22
Current: 1.83

During the past 9 years, Algernon Pharmaceuticals's highest PB Ratio was 18.22. The lowest was 0.00. And the median was 0.00.

AGNPF's PB Ratio is ranked better than
70.08% of 1310 companies
in the Biotechnology industry
Industry Median: 2.385 vs AGNPF: 1.83

During the past 12 months, Algernon Pharmaceuticals's average Book Value Per Share Growth Rate was -83.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -63.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -38.00% per year.

During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of Algernon Pharmaceuticals was 15.00% per year. The lowest was -63.10% per year. And the median was -5.15% per year.

Back to Basics: PB Ratio

Algernon Pharmaceuticals PB Ratio Historical Data

The historical data trend for Algernon Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Algernon Pharmaceuticals PB Ratio Chart

Algernon Pharmaceuticals Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

PB Ratio

Get a 7-Day Free Trial

1.14

3.80

1.79

2.22

1.74

Algernon Pharmaceuticals Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
PB Ratio	Get a 7-Day Free Trial															1.31	1.13	0.80	1.74	1.36

Competitive Comparison of Algernon Pharmaceuticals's PB Ratio

For the Biotechnology subindustry, Algernon Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Algernon Pharmaceuticals's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Algernon Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Algernon Pharmaceuticals's PB Ratio falls into.

Algernon Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Algernon Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Nov. 2023)
	=	0.091435	/	0.047
	=	1.95

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Algernon Pharmaceuticals (OTCPK:AGNPF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Algernon Pharmaceuticals PB Ratio Related Terms

Thank you for viewing the detailed overview of Algernon Pharmaceuticals's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Algernon Pharmaceuticals (Algernon Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Algernon Pharmaceuticals Inc (OTCPK:AGNPF) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

AGW0:Germany AGN:Canada

Address

601 West Broadway, Suite 400, Vancouver, BC, CAN, V5Z 4C2

Website

https://www.algernonpharmaceuticals.com

Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis and chronic cough. The company's business model is capital efficient and strives to deliver maximum shareholder value. Algernon's approach to drug discovery is based on the concept of drug repurposing. It operates in two reportable segments: the development of repurposed therapeutic drugs in Canada, and the facilitation of the Company's drug candidates into off-label phase II clinical trials (humans) in Australia.